A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity. [electronic resource]
Producer: 19950509Description: 1881-7 p. digitalISSN:- 0006-4971
- Acute Disease
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bone Marrow -- pathology
- Bone Marrow Transplantation
- Carboplatin -- administration & dosage
- Chromosomes, Human, Pair 13 -- ultrastructure
- Chromosomes, Human, Pair 8 -- ultrastructure
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Cytarabine -- administration & dosage
- Daunorubicin -- administration & dosage
- Doxorubicin -- administration & dosage
- Eosinophilia -- genetics
- Etoposide -- administration & dosage
- Fatal Outcome
- Female
- Humans
- Hydroxyurea -- therapeutic use
- Hyperplasia
- Ifosfamide -- administration & dosage
- Leukemia, Myeloid -- genetics
- Lymph Nodes -- pathology
- Male
- Middle Aged
- Mitoxantrone -- administration & dosage
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- genetics
- Prednisone -- administration & dosage
- Pregnancy
- Pregnancy Complications, Neoplastic -- drug therapy
- Remission Induction
- Syndrome
- Translocation, Genetic
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Case Reports; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.